Increasing Utilization of Allogeneic Bone Marrow Transplantation
Annals of Internal MedicinePublished 15 March 1992
Mortimer M. Bortin, M. Horowitz, Alfred A. Rimm
Citations123
SJR quartileQ1
SJR score3.38
SNIP3.27
Generate an AI Snapshot to get a quick, structured summary of this paper.
Study Snapshot
ObjectiveStudy objective
MethodsResearch methodology
PopulationPopulation studied
Sample sizeSample sizes
OutcomesStudy outcomes here
ResultsStudy results comes here
LimitationsResearch study limitations comes here
A concise AI-generated summary of the paper will appear here once you click Generate AI Snapshot.
TL;DR
The use of allogeneic bone marrow transplantation continued to increase at a rate of more than 600 additional patients and 25 new transplant teams annually between 1988 and 1990, due in part to increasing use of unrelated volunteers as donors.
Abstract
The use of allogeneic bone marrow transplantation continued to increase at a rate of more than 600 additional patients and 25 new transplant teams annually. This rise is due in part to increasing use of unrelated volunteers as donors. Resources allocated for transplants vary widely among countries.
Keywords
Medicine
Nursing Clinics of North AmericaBone Marrow Transplant
2,735 Citations1990Rosemary Ford, Seth Eisenberg
New England Journal of MedicineMethotrexate and Cyclosporine Compared with Cyclosporine Alone for Prophylaxis of Acute Graft versus Host Disease after Marrow Transplantation for Leukemia
1,446 Citations1986Rainer Storb, H. Joachim Deeg +19 more
It is concluded that the combination of methotrexate and cyclosporine is superior to cyclOSporine alone in the prevention of acute graft versus host disease after marrow transplantation for leukemia, and that this therapy may have a beneficial effect on long-term survival.
The LancetIMMUNOLOGICAL RECONSTITUTION OF SEX-LINKED LYMPHOPENIC IMMUNOLOGICAL DEFICIENCY
1,017 Citations1968RichardA. Gatti, HilaireJ. Meuwissen +3 more
Treatment of a 5-month-old male with sex-linked lymphopenic immunological deficiency utilising immunologically competent cells from peripheral blood buffy coat and bone-marrow of a sibling donor resulted in reconstitution of both cellular and humoral immunity.
The LancetBONE-MARROW TRANSPLANTATION IN A PATIENT WITH THE WISKOTT-ALDRICH SYNDROME
863 Citations1968F H Bach, RichardJ. Albertini +3 more
New England Journal of MedicineMarrow Transplantation from Related Donors Other Than HLA-Identical Siblings
837 Citations1985Patrick G. Beatty, Reginald A. Clift +10 more
In a study of the acceptable limits of HLA incompatibility, 105 consecutive patients with hematologic cancers who received marrow grafts from haploidentical donors were compared with 728 similar patients concurrently receiving grafting from HLA genotypically identical siblings.
BloodA prospective study of androgens and bone marrow transplantation for treatment of severe aplastic anemia
430 Citations1979BM Camitta, Thomas Ed +7 more
The LancetMARROW TRANSPLANTATION FOR THALASSAEMIA
335 Citations1982E. Donnall Thomas, Jean E. Sanders +7 more
The LancetALLOGENEIC BONE-MARROW TRANSPLANTATION FOR CHRONIC MYELOGENOUS LEUKAEMIA
265 Citations1984B Speck, M. M. Bortin +7 more
It is demonstrated that long-term disease-free survival in CML can be achieved with bone-marrow transplantation, and best results were obtained in patients transplanted during chronic phase of the disease.
New England Journal of MedicineSuccessful Allogeneic Transplantation of T-Cell–Depleted Bone Marrow from Closely HLA-Matched Unrelated Donors
263 Citations1990Robert C. Ash, James T. Casper +13 more
It is concluded that marrow transplantation with closely HLA-matched unrelated donors can be effective treatment for neoplastic and non-neoplastic diseases and transplants with limited HLA disparity can also be successful in some patients.
British Medical BulletinEVOLUTION AND FUNCTION OF THE HLA SYSTEM
229 Citations1978Walter F. Bodmer, J. G. Bodmer
PubMedBone marrow transplantation from related donors other than HLA-identical siblings: effect of T cell depletion.
198 Citations1991Robert C. Ash, Mary M. Horowitz +8 more
T cell depletion increased graft failure and decreased acute GVHD after alternative related donor transplants but did not improve leukemia-free survival, and factors associated with transplant outcome were analysed.
Annals of Internal MedicineChemotherapy Compared with Bone Marrow Transplantation for Adults with Acute Lymphoblastic Leukemia in First Remission
163 Citations1991Mary M. Horowitz
The results suggest that bone marrow transplants currently offer no special advantage over chemotherapy for adults with acute lymphoblastic leukemia in first remission.
TransplantationINCREASING UTILIZATION OF BONE MARROW TRANSPLANTATION
92 Citations1986Mortimer M. Bortin, Alfred A. Rimm
Cette croissance va probablement se continuer, la greffe de moelle donnant de meilleurs resultats que d'autres traitements au cours d'hemopathies malignes, thalassemies ou autres affections.
PubMedMarrow transplantation for thalassemia.
82 Citations1986Kai‐Hsin Lin, Lin Ks +1 more
It is demonstrated that bone marrow transplantation may cure thalassemia, but engraftment may be jeopardized among patients who have been heavily transfused or have received marrow from a donor who is not HLA-identical.
PubMedBone marrow transplantation activity in Europe 1990. European Group for Bone Marrow Transplantation (EBMT)
78 Citations1991Aloïs Gratwohl
This survey of the European Group for Bone Marrow Transplantation on transplant activity clearly indicates that within the last decade bone marrow transplantation has become an established therapy in Europe.
PubMedThe use of unrelated bone marrow donors in the treatment of patients with chronic myelogenous leukemia: experience of four marrow transplant centers.
74 Citations1989Beatty Pg, Ash R +2 more
Results indicate that marrow grafting from either HLA-identical or HLA one locus-mismatched volunteer donors may be effective therapy for patients with chronic myelogenous leukemia who lack an acceptable related donor.
TransplantationINCREASING UTILIZATION OF BONE MARROW TRANSPLANTATION
71 Citations1989M. M. Bortin, Alfred A. Rimm
The data reflect continued growth in utilization of allogeneic and syngeneic bone marrow transplantation and quantify the annual increases in the number of patients receiving transplants.
BloodUnrelated donor bone marrow transplantation therapy for chronic myelogenous leukemia
63 Citations1987P McGlave, E Scott +5 more
Unrelated donor BMT can be effective in the treatment of CML and may be particularly useful in this disorder since the prolonged stable phase of disease offers an opportunity to locate suitable donors.
BloodShould HLA-identical sibling bone marrow transplants for leukemia be restricted to large centers? [see comments]
43 Citations1992MM Horowitz, Donna Przepiorka +8 more
PubMedProphylaxis of cytomegalovirus infection.
28 Citations1990Bowden Ra, Meyers Jd
Suppression of CMV with antiviral agents may be the most effective means of preventing disease due to viral reactivation, although this result warrants confirmation.
PubMedAutotransplants: now and in the future.
16 Citations1991R P Gale, J. O. Armitage +1 more
There is much enthusiasm for autotransplants; their use is expanding very rapidly but controlled and/or randomized trials are now needed to evaluate efficacy in other settings and how to achieve this balance is presently uncertain.
Organisation of a Hospital Bone Marrow Panel
8 Citations1984D. C. O. James
The first unrelated bone marrow transplant carried out in 1973 at Westminster Hospital was possible only after considerable effort in locating the compatible donor, and it was obvious that a panel or register of previous HLA-tested donors based on the blood transfusion service system was highly desirable.